What are the potential mechanisms by which rosuvastatin might contribute to weight loss or reduction in visceral fat?

No direct evidence for the mechanisms by which rosuvastatin contributes to weight loss or reduction in visceral fat was identified. Indirect evidence suggests improvements in insulin sensitivity, lipid metabolism, and inflammatory profiles might play roles.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24378135
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the potential mechanisms by which rosuvastatin might contribute to weight loss or reduction in visceral fat?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Lipoproteins and Cardiovascular Health
article

What are the potential mechanisms by which rosuvastatin might contribute to weight loss or reduction in visceral fat?

Tripdatabase
article en

Abstract

No direct evidence for the mechanisms by which rosuvastatin contributes to weight loss or reduction in visceral fat was identified. Indirect evidence suggests improvements in insulin sensitivity, lipid metabolism, and inflammatory profiles might play roles.

Zenodo (CERN European Organization for Nuclear Research)
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon